National Taiwan University Hospital: Schizophrenia trials

The registry lists 32 Schizophrenia studies with National Taiwan University Hospital as lead sponsor. 3 are open to participants now and 1 have results posted.

Phase 3 2Phase 4 5No phase 25(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Autonomic Nervous System and Meridian Energy in Patients With SchizophreniaRecruitingNCT06617104
• Develop a Novel Occupational Training Program for Schizophrenia Patients Based on Virtual Reality TechniquesRecruitingNCT05830903Not applicable
• rTMS for Depressive, Positive and Negative Symptoms, and Physiological Indices of Schizophrenia PatientsRecruitingNCT05671185Not applicable
• Intramuscular (IM) Olanzapine Versus IM Haloperidol Plus Lorazepam for Acute Agitation in SchizophreniaCompletedNCT00797277Phase 3Results posted
• A Computational Neuroscience Perspective on the Shared Social Cognitive Deficits of Autism and SchizophreniaActive, not recruitingNCT07618767
• Exploring the Health Effects of Group Game-based Activities on Individuals With Chronic Mental IllnessCompletedNCT06440200Not applicable
• Biological Implications of the Overlapping Phenomenon Between Childhood Schizophrenia and Autism Spectrum Disorders-Heterogeneity Approach Rather Than Diagnostic BoundaryStatus unknownNCT06063525
• rTMS on Mismatch Negativity of SchizophreniaStatus unknownNCT04012684Not applicable
• Pharmacokinetics and Safety Studies of Esomeprazole Use in Schizophrenia PatientsCompletedNCT03333603Phase 4
• A Pharmacokinetic Study of Paliperidone ERStatus unknownNCT02433717Phase 4
• Effect of Memantine on ERP in Early Schizophrenia and Healthy SubjectsStatus unknownNCT02233556Not applicable
• Memantine add-on for Cognitive and Negative Symptoms of SchizophreniaStatus unknownNCT02001103Phase 3
• The Evaluation of Therapeutic Efficacy on the Integrated Group Psychotherapy for Patients With SchizophreniaCompletedNCT01139099Not applicable
• Trial for Antidepressant Treatment for Negative Symptom of Schizophrenia With NRG1 Risk GenotypeStatus unknownNCT01078870Phase 4
• Expanding Rapid Ascertainment Networks of Schizophrenia Families in TaiwanCompletedNCT01077687
• A Neurobiological Study on Heterogeneity of Schizophrenia: Genetic Variations and Neurobiological DifferentiationsStatus unknownNCT01075373
• Quetiapine Related Neurochemical Changes as Measured by Magnetic Resonance Spectroscopy in SchizophreniaCompletedNCT00797927Phase 4
• Evaluation of the Strategies of Switching Schizophrenia Patients to Aripiprazole From Other Antipsychotic AgentsCompletedNCT00545467Phase 4
• The Quality of Life of Patients With Severe IllnessesStatus unknownNCT00173329
• A Study on Psychopathological Progress of Early Schizophrenia-Like Disorder (SOPRES)Status unknownNCT00173069
• The Establishment of the Early Intervention Program for Patients With SchizophreniaStatus unknownNCT00172770
• Measurement of Activity Participation for Persons With Schizophrenia Living in the CommunityCompletedNCT00172731
• Aggressive Acts Among Patients With SchizophreniaSuspendedNCT00172497
• Analysis of Genomic DNA Alterations in Familial SchizophreniaStatus unknownNCT00166738
• Mutation Screening and Translocation Detection of DISC1 Gene in SchizophreniaCompletedNCT00155818
• Mutation Screening and Translocation Detection of DISC1 Gene in SchizophreniaCompletedNCT00155701
• A Genetic Linkage Study of SchizophreniaCompletedNCT00155688
• A Positional Cloning Study on SchizophreniaCompletedNCT00155649
• A Study on Etiological Factors of SchizophreniaTerminatedNCT00155636
• A Psychopathological Study of Latent (Early) Schizophrenia: Clinical Pathology/Neuropsychological DysfunctionsCompletedNCT00155519
• Molecular Genetic Study of Schizophrenia: Parent-Offspring TriosCompletedNCT00155506
• A Study on Risk Mutations of Vulnerability Genes of SchizophreniaStatus unknownNCT00155207